Related references
Note: Only part of the references are listed.MicroRNA-222-3p associated with Helicobacter pylori targets HIPK2 to promote cell proliferation, invasion, and inhibits apoptosis in gastric cancer
Xiaoyan Tan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
MicroRNA-197 induces epithelial-mesenchymal transition and invasion through the downregulation of HIPK2 in lung adenocarcinoma
Nan Zhang et al.
JOURNAL OF GENETICS (2018)
HIPK2-Mediated Transcriptional Control of NMDA Receptor Subunit Expression Regulates Neuronal Survival and Cell Death
Yulei Shang et al.
JOURNAL OF NEUROSCIENCE (2018)
Challenges in diagnosis of pancreatic cancer
Lulu Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Targeting the MAPK Pathway in RAS Mutant Cancers
Sarah G. Hymowitz et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses
L. Torrente et al.
ONCOGENE (2017)
MYC and tumor metabolism: chicken and egg
Francesca R. Dejure et al.
EMBO JOURNAL (2017)
Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer
Stine F. Pedersen et al.
BIOESSAYS (2017)
MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies
E. Hessmann et al.
ONCOGENE (2016)
Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1
Eun-Jung Ann et al.
CANCER RESEARCH (2016)
Concepts to Target MYC in Pancreatic Cancer
Matthias Wirth et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Pancreatic cancer biology and genetics from an evolutionary perspective
Alvin Makohon-Moore et al.
NATURE REVIEWS CANCER (2016)
Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function
N. V. Rajeshkumar et al.
CANCER RESEARCH (2015)
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer
Shunrong Ji et al.
CELL RESEARCH (2015)
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions
Linchong Sun et al.
CELL RESEARCH (2015)
Integration of stress signals by homeodomain interacting protein kinases
Michael Lienhard Schmitz et al.
BIOLOGICAL CHEMISTRY (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Targeting RAS-ERK signalling in cancer: promises and challenges
Ahmed A. Samatar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Downregulation of HIPK2 Increases Resistance of Bladder Cancer Cell to Cisplatin by Regulating Wip1
Jun Lin et al.
PLOS ONE (2014)
HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis
Thomas G. Hofmann et al.
BIOESSAYS (2013)
The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
Bryan King et al.
CELL (2013)
Homeodomain-interacting protein kinase 2-dependent repression of myogenic differentiation is relieved by its caspase-mediated cleavage
Laureano de la Vega et al.
NUCLEIC ACIDS RESEARCH (2013)
Notch signaling in pancreatic cancer: oncogene or tumor suppressor?
Jacqueline L. Avila et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis
Yumin Hu et al.
CELL RESEARCH (2012)
Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
Anne Le et al.
CLINICAL CANCER RESEARCH (2012)
Targeting Cancer Metabolism
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2012)
Homeodomain-Interacting Protein Kinase Regulates Hippo Pathway-Dependent Tissue Growth
Carole L. C. Poon et al.
CURRENT BIOLOGY (2012)
Depletion of homeodomain-interacting protein kinase 3 impairs insulin secretion and glucose tolerance in mice
N. Shojima et al.
DIABETOLOGIA (2012)
Targeting glucose metabolism for cancer therapy
Robert B. Hamanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Energy metabolism and proliferation in pancreatic carcinogenesis
Ivonne Regel et al.
LANGENBECKS ARCHIVES OF SURGERY (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage
C. Lazzari et al.
ONCOGENE (2011)
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Jennifer A. Mertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
The WD40-repeat protein Han11 functions as a scaffold protein to control HIPK2 and MEKK1 kinase functions
Stefanie Ritterhoff et al.
EMBO JOURNAL (2010)
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
John P. Morris et al.
NATURE REVIEWS CANCER (2010)
Transcriptional regulation of hypoxia-inducible factor 1α by HIPK2 suggests a novel mechanism to restrain tumor growth
Lavinia Nardinocchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage
S. Iacovelli et al.
CELL PROLIFERATION (2009)
Hipk is an essential protein that promotes Notch signal transduction in the Drosophila eye by inhibition of the global co-repressor Groucho
Wendy Lee et al.
DEVELOPMENTAL BIOLOGY (2009)
Inhibition of HIF-Ialpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis
Lavinia Nardinocchi et al.
MOLECULAR CANCER (2009)
A positive role for Myc in TGFβ-induced Snail transcription and epithelial-to-mesenchymal transition
A. P. Smith et al.
ONCOGENE (2009)
SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis
X. Li et al.
CELL DEATH AND DIFFERENTIATION (2008)
Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9
Shigeki Arai et al.
FEBS LETTERS (2007)
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation
John D. Gordan et al.
CANCER CELL (2007)
MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis
Cinzia Rinaldo et al.
MOLECULAR CELL (2007)
Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function
Stephen R. Hann
SEMINARS IN CANCER BIOLOGY (2006)
Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2
Ekaterina Gresko et al.
EMBO JOURNAL (2006)
Tumor necrosis factor α-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1 are critical for apoptosis signal-regulating kinase 1-JNK/p38 activation
XH Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis
QH Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP
OH Zhang et al.
CELL (2003)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
Share Paper
